S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
An Unusual Way to Invest in Gold (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
New CBOE “special perk” helps traders target income every weekend (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
New CBOE “special perk” helps traders target income every weekend (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
An Unusual Way to Invest in Gold (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
New CBOE “special perk” helps traders target income every weekend (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
New CBOE “special perk” helps traders target income every weekend (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
An Unusual Way to Invest in Gold (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
New CBOE “special perk” helps traders target income every weekend (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
New CBOE “special perk” helps traders target income every weekend (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
An Unusual Way to Invest in Gold (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
New CBOE “special perk” helps traders target income every weekend (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
New CBOE “special perk” helps traders target income every weekend (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary

iShares Genomics Immunology and Healthcare ETF (IDNA) Price, Holdings, & News

$21.11
+0.11 (+0.52%)
(As of 12/7/2023 ET)
Compare
Today's Range
$20.91
$21.18
50-Day Range
$17.37
$21.29
52-Week Range
$17.33
$28.06
Volume
73,700 shs
Average Volume
29,063 shs
Market Capitalization
$127.72 million
Assets Under Management
$120.94 million
Dividend Yield
0.66%
Net Expense Ratio
0.47%

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.

IDNA Stock Price History

IDNA ETF News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
IDNA ETF Stock Price History
IBDT iShares iBonds Dec 2028 Term Corporate ETF
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
IDNA iShares Genomics Immunology and Healthcare ETF
See More Headlines
Receive IDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
iShares
Fund Name
iShares Genomics Immunology and Healthcare ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:IDNA
Inception Date
6/11/2019
Fund Manager
Jennifer Hsui, Greg Savage, Paul Whitehead
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
58

Fund Statistics

Assets Under Management
$120.94 million
Average Daily Volume
$0.00
Discount/Premium
-0.03%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
BlackRock Fund Advisors
Custodian
State Street Bank and Trust Company
Distributor
BlackRock Investments, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
500 shs

Miscellaneous

Beta
0.90
Creation Unit
50,000
Creation Fee
$850.00
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

iShares Genomics Immunology and Healthcare ETF Expenses

TypeIDNATheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.47%0.57%0.53%0.50%0.51%
Other Expenses0.00%0.76%0.54%0.64%0.57%
Total Expense0.47%0.73%0.70%0.73%0.70%
Fee Waiver0.00%-0.78%-0.54%-0.69%-0.57%
Net Expense0.47%0.60%0.60%0.57%0.57%

iShares Genomics Immunology and Healthcare ETF (IDNA) Holdings & Exposure

Top 10 IDNA Holdings

IDNA Sector Exposure

IDNA Industry Exposure















IDNA ETF - Frequently Asked Questions

How have IDNA shares performed in 2023?

iShares Genomics Immunology and Healthcare ETF's stock was trading at $25.17 at the beginning of the year. Since then, IDNA shares have decreased by 16.1% and is now trading at $21.11.
View the best growth stocks for 2023 here
.

What does IDNA invest in?

iShares Genomics Immunology and Healthcare ETF is a equity fund issued by iShares. IDNA focuses on theme investments and follows the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund's investments total to approximately $120.94 million assets under management.

What stocks does iShares Genomics Immunology and Healthcare ETF hold?
What is the management fee for iShares Genomics Immunology and Healthcare ETF?

iShares Genomics Immunology and Healthcare ETF's management fee is 0.47% and has no other recorded expenses or fee waivers. The net expense ratio for IDNA is 0.47%.

What other stocks do shareholders of iShares Genomics Immunology and Healthcare ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Genomics Immunology and Healthcare ETF investors own include Pfizer (PFE), Gilead Sciences (GILD), Intel (INTC), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Novavax (NVAX), Canadian Natural Resources (CNQ), QUALCOMM (QCOM), SPDR S&P Biotech ETF (XBI) and Bristol-Myers Squibb (BMY).

Who are iShares Genomics Immunology and Healthcare ETF's major shareholders?

iShares Genomics Immunology and Healthcare ETF's stock is owned by many different institutional and retail investors. Top institutional investors include Ameriprise Financial Inc. (1.63%), Integrated Wealth Concepts LLC (0.94%) and RiverFront Investment Group LLC (0.68%).

How do I buy shares of iShares Genomics Immunology and Healthcare ETF?

Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSEARCA:IDNA) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -